This session will provide a comparative overview of US and EU requirements, including sponsor review of investigator safety data. Several gnarly examples will be presented for group discussion.

Have an account?

Pragmatic Approaches to Drug Safety Across the Premarketing and Postmarketing Continuum

Session 8: Assessing Individual Cases and Expedited Case Reporting, Part 2

Session Chair(s)

JP Clement, MD

Be informed and stay engaged.